| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CSGALNACT2 mRNA | CTD | PMID:17101203 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1556873 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CSGALNACT2 mRNA | CTD | PMID:21570461 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CSGALNACT2 mRNA | CTD | PMID:21641981 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CSGALNACT2 mRNA | CTD | PMID:21641981 PMID:22100608 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1556873 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of CSGALNACT2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CSGALNACT2 mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | increases expression | ISO | RGD:1556873 | 6480464 | Benzo(a)pyrene results in increased expression of CSGALNACT2 mRNA | CTD | PMID:19770486 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of CSGALNACT2 mRNA | CTD | PMID:19376846 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of CSGALNACT2 mRNA | CTD | PMID:19549813 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of CSGALNACT2 mRNA | CTD | PMID:18687144 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CSGALNACT2 mRNA | CTD | PMID:20106945 |
| paracetamol | affects expression | ISO | RGD:1556873 | 6480464 | Acetaminophen affects the expression of CSGALNACT2 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CSGALNACT2 mRNA | CTD | PMID:21420995 PMID:22230336 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CSGALNACT2 mRNA | CTD | PMID:21420995 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CSGALNACT2 mRNA | CTD | PMID:21632981 |
| succimer | multiple interactions | ISO | RGD:1556873 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CSGALNACT2 mRNA | CTD | PMID:21641980 |
| valproic acid | increases expression | ISO | RGD:1556873 | 6480464 | Valproic Acid results in increased expression of CSGALNACT2 mRNA | CTD | PMID:19136453 |
| zebularine | increases expression | EXP | | 6480464 | pyrimidin-2-one beta-ribofuranoside results in increased expression of CSGALNACT2 mRNA | CTD | PMID:19194470 |